| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 12/22/2009 | US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide |
| 12/22/2009 | US7635774 Benzimidazole derivatives |
| 12/22/2009 | US7635713 Preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, eclampsia, or eosinophil disorder; use in combination with a phosphodiesterase inhibitor; e.g. (5Z)-7-{1-[3-hydroxy-4-(3-methylphenyl)butyl]-3-oxopyrrolidin-2-yl}hept-5-enoic acid |
| 12/22/2009 | US7635692 In form of concentrate or dietary composition such as fortified foods, fortified feed and beverages, or in the form of different galenical formulations such as tablets, granules filled into capsules, or effervescent formulations |
| 12/22/2009 | US7635686 Cancer treatment with a synthetic sequences |
| 12/22/2009 | US7635684 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 12/22/2009 | US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
| 12/22/2009 | US7635592 Generating tissue solid support; obtain matrix intensifying particles, couple to solid support, incubate with cell and growth factor, propagate tissue |
| 12/22/2009 | US7635472 single chain antibody construct comprising binding domains specific for human CD3 and human CD19; anticarcinogenic biodrug for treating non-Hodgkin lymphoma |
| 12/22/2009 | US7635464 Selective targeting of apoptotic cells |
| 12/22/2009 | CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/22/2009 | CA2415214C Phosphotetrahydropyran compounds |
| 12/22/2009 | CA2402421C Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 12/22/2009 | CA2369587C Solubilized pharmaceutical composition for parenteral administration |
| 12/22/2009 | CA2330190C Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
| 12/22/2009 | CA2326529C 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide |
| 12/17/2009 | WO2009152493A2 Use of apolipoproteins to decrease inflammation |
| 12/17/2009 | WO2009152072A1 Pyrrolo [2, 3-c] pyridine derivatives as p38 kinase inhibiting agents |
| 12/17/2009 | WO2009151770A2 Colchicine solid-state forms; methods of making; and methods of use thereof |
| 12/17/2009 | WO2009151634A1 Complement inhibitory agents as therapeutics in posttraumatic and degenerative arthritis |
| 12/17/2009 | WO2009151626A1 Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists |
| 12/17/2009 | WO2009151621A1 Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists |
| 12/17/2009 | WO2009151094A1 HUMAN β3 ADRENERGIC RECEPTOR LIGAND, AND FOOD OR PHARMACEUTICAL PRODUCT CONTAINING THE SAME |
| 12/17/2009 | WO2009150310A1 Use of the pat nonapeptide in the treatment of autoimmune diseases |
| 12/17/2009 | WO2009150118A2 Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid |
| 12/17/2009 | WO2009117669A3 Treatment with opioid antagonists and mtor inhibitors |
| 12/17/2009 | WO2009080778A3 Preparations with rosehip extracts, and method of producing rosehip extracts |
| 12/17/2009 | WO2008109727A8 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
| 12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
| 12/17/2009 | US20090312430 Colchicine solid-state forms; methods of making; and methods of use thereof |
| 12/17/2009 | US20090312425 Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 12/17/2009 | US20090312376 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases |
| 12/17/2009 | US20090312351 Processes for the Preparation of Alfuzosin |
| 12/17/2009 | US20090312342 Quinazolines useful as modulators of ion channels |
| 12/17/2009 | US20090312334 Immunomodulating Heterocyclic Compounds |
| 12/17/2009 | US20090312313 Compound having tgfbeta inhibitory activity and pharmaceutical composition comprising the same |
| 12/17/2009 | US20090312289 Ibandronate polymorph |
| 12/17/2009 | US20090312288 Kinase inhibitors |
| 12/17/2009 | US20090312283 Branched hyaluronic acid and method of manufacture |
| 12/17/2009 | US20090312274 Nyasol and Analogs Thereof for the Treatment of Estrogen Receptor Beta-Mediated Diseases |
| 12/17/2009 | US20090312253 Methods of effecting Wnt signaling through Dkk structural analysis |
| 12/17/2009 | US20090312245 SRA binding protein |
| 12/17/2009 | US20090311792 Fibroblast growth factor (FGF23) and methods for use |
| 12/17/2009 | US20090311353 Equal-containing fermentation product of soybean embryonic axis, and method for production thereof |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 12/17/2009 | US20090311221 Biomaterials for regenerative medicine |
| 12/17/2009 | US20090311220 Bone forming compound composed of a mixture of osteoblast and biomatrix and method for producing the same |
| 12/17/2009 | US20090311179 Selective Targeting of Apoptotic Cells |
| 12/17/2009 | DE102008015432A1 Verwendung von Pirinixinsäure-Derivaten zur Hemmung der Prostaglandin E2 Synthese Use of Pirinixinsäure derivatives for the inhibition of prostaglandin E2 synthesis |
| 12/17/2009 | CA2727587A1 Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid |
| 12/17/2009 | CA2727315A1 Pyrrolo [2, 3-c] pyridine derivatives as p38 kinase inhibiting agents |
| 12/17/2009 | CA2727242A1 Pyrazole derivatives useful as inhibitors of faah |
| 12/17/2009 | CA2727223A1 Human .beta.3 adrenergic receptor ligand, and food or pharmaceutical product containing the same |
| 12/16/2009 | EP2133432A1 Use of snail1 activity inhibiting compounds in the preparation of pharmaceutical compositions intended for the treatment of chondrodystrophies, method for identifying inhibiting compounds, pharmaceutical compositions, chondrodystrophy diagnosis method and applications thereof |
| 12/16/2009 | EP2133331A1 5-membered heterocyclic derivative and use thereof for medical purposes |
| 12/16/2009 | EP2133070A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 12/16/2009 | EP2132568A1 Method of determining risk of scoliosis |
| 12/16/2009 | EP2132220A1 Integrin targeted cyclopeptide ligands, their preparation and use |
| 12/16/2009 | EP2132173A1 Formulations for cathepsin k inhibitors |
| 12/16/2009 | EP2131833A2 Use of resolvins for inhibition of bone loss |
| 12/16/2009 | EP1830848B1 Use of thiazolidinone derivatives for the treatment of solid tumors |
| 12/16/2009 | EP1619180B1 CaSR ANTAGONIST |
| 12/16/2009 | CN101602996A Health preserving and health care wine and preparation method thereof |
| 12/16/2009 | CN101602731A Metalloproteinase inhibitors |
| 12/16/2009 | CN101601861A Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component |
| 12/16/2009 | CN101601858A Application of midkine protein and medical device containing protein |
| 12/16/2009 | CN101601854A Health care spirit |
| 12/16/2009 | CN101601851A External application patch for treating scapulohumeral periarthritis and preparation technology thereof |
| 12/16/2009 | CN101601849A Manufacturing method of hyperosteogeny liniment |
| 12/16/2009 | CN101601847A Preparation method of rheumatalgia-relieving spasmolysis oral wine |
| 12/16/2009 | CN101601841A Medicament for treating rheumatism and traumatic injury |
| 12/16/2009 | CN101601839A Manufacturing method of external solution for rheumatoid arthritis |
| 12/16/2009 | CN101601838A Manufacturing method of external solution for enabling lumbar disc herniation to recover |
| 12/16/2009 | CN101601837A Manufacturing method external analgesic solution for neck and shoulder diseases |
| 12/16/2009 | CN101601824A Preparation method of ledebouriella root and pubescent angelica root oral wine |
| 12/16/2009 | CN101601818A Chinese medicine preparation for treating rheumatic and rheumatoid arthritis |
| 12/16/2009 | CN101601809A Preparation method of fengshidieda oral wine |
| 12/16/2009 | CN101601804A Traditional Chinese patent medicine for treating lumbago caused by wrench |
| 12/16/2009 | CN101601796A Chinese medicinal fuming-steaming composition for treating arthralgia syndrome, and guiding medicament thereof |
| 12/16/2009 | CN101601786A Preparation method of medicinal preparation for quickly curing gout disease |
| 12/16/2009 | CN101601770A Chinese medicine for treating arthralgia and lumbago and preparation method thereof |
| 12/16/2009 | CN101601746A Preparation method of tendon relaxing agent |
| 12/16/2009 | CN101601662A Alendronate sodium intestine-sol capsule and preparation method thereof |
| 12/16/2009 | CN101601661A Residronate sodium tablet and preparation method thereof |
| 12/16/2009 | CN101601654A Hydrochloric acid Fasudil liposome injection and new application thereof |
| 12/16/2009 | CN101601643A Skeleton hemostasis gel |
| 12/16/2009 | CN101601468A Preparation method of wolfberry fruit and broomrape tonic wine |
| 12/16/2009 | CN101601466A Preparation method of oral wine for tonifying kidney, strengthening waist and relaxing muscles and tendons |
| 12/16/2009 | CN100569796C Immune modulating peptide |
| 12/16/2009 | CN100569283C Calcium-tablet for preventing osteoporosis |
| 12/16/2009 | CN100569282C Injection bone peptide freeze-drying preparation and its making method |
| 12/16/2009 | CN100569281C Preparation and use of compositions for treating and preventing necrosis |
| 12/16/2009 | CN100569248C Pharmaceutical composition for treating paralysis |
| 12/16/2009 | CN100569245C Application of frankincense in preparing medication for curing gout |
| 12/16/2009 | CN100569241C Celery seed ethyl acetate extract and use thereof |
| 12/16/2009 | CN100569221C Preparation of Chinese medicine of clearing away heat and promoting diuresis, promoting blood circulation and activating the channels, and preparation method thereof |
| 12/16/2009 | CN100569199C External use plaster for treating acute jerk contused wound |
| 12/15/2009 | US7632951 Inhibitors of integrin ανβ6 |
| 12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |